header-txt

Digital Solutions

imgToBackground
Loading...
row-start col-md-7 top-section new-section

How can we improve public health, screening programmes and diagnostics, particularly at the point of care rather than at a laboratory (considering early diagnosis and intervention improves outcomes and saves lives, effort and money all round)?

The NHS Diabetes Prevention Programme (NHS DPP) deliver at scale, evidence based behavioural interventions and personalised support for individuals identified as being at high risk of developing Type 2 diabetes.

Public Health England (PHE) have perhaps the world's best programme for screening - as well as the world's best cancer registry.

X-Labs helped to build the National Pathology Exchange (NPEx) for the NHS linking all pathology laboratories in the UK utilising HL7 messaging standard and SNOMED-CT coding, designed from the outset to be fast, safe and scalable to run all lab-to-lab messaging for the nation.

The UK has five centres of excellence to demonstrate how digital pathology and radiology with AI can work in practice in the NHS and save lives supported by £50m from the Industrial Strategy Challenge Fund. They are based in Leeds, Oxford, Coventry, Glasgow and London – but each with partners across many parts of the UK .

Owlstone Medical developed a breathalyzer for disease for the early detection of cancer, inflammatory and infectious disease with a mission is to save 100,000 lives.

The NHS is supported by a wide range of next generation point of care diagnostic technology firms such as LumiraDx , ElectronRx and QuantuMDx all offering portable, clinical grade, laboratory-accurate diagnostics, providing answers within minutes.

row-end col-sm-12 col-md-5